Los Angeles Capital Management
IMNM icon

Los Angeles Capital Management’s Immunome IMNM Stock Holding History

Los Angeles Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$174K Sell
8,221
-60
-0.7% -$1.28K ﹤0.01% 1204
2026
Q1 		$181K Sell
8,281
-51,136
-86% -$1.14M ﹤0.01% 1172
2025
Q4 		$949K Sell
59,417
-27,685
-32% -$486K ﹤0.01% 643
2025
Q3 		$1.02M Buy
87,102
+45,245
+108% +$450K ﹤0.01% 702
2025
Q2 		$389K Buy
41,857
+6,009
+17% +$49.3K ﹤0.01% 954
2025
Q1 		$241K Buy
35,848
+127
+0.4% +$1.22K ﹤0.01% 962
2024
Q4 		$379K Buy
+35,721
New +$432K ﹤0.01% 878

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Los Angeles Capital Management's IMNM Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Immunome (IMNM) stake by 0.72% in Q2 2026, selling an estimated $1.28K and leaving 8,221 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #1204.

Los Angeles Capital Management first reported a position in IMNM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.02M in Q3 2025. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Los Angeles Capital Management held 8,221 shares of Immunome worth $174K as of Q2 2026.
  • Los Angeles Capital Management sold 60 Immunome shares in Q2 2026, an estimated $1.28K.
  • Immunome made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1204 holding.
  • Los Angeles Capital Management first reported a position in Immunome in Q4 2024 and has held it in 7 quarters since.
  • Los Angeles Capital Management's Immunome position peaked at $1.02M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.